These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 1562994)
1. Methods and strategies in lung cancer control. Castonguay A Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994 [TBL] [Abstract][Full Text] [Related]
2. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials. Greenwald P J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595 [TBL] [Abstract][Full Text] [Related]
3. Risk biomarkers and current strategies for cancer chemoprevention. Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592 [TBL] [Abstract][Full Text] [Related]
4. The role of chemoprevention in cancer control. Greenwald P; Kelloff GJ IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016 [TBL] [Abstract][Full Text] [Related]
5. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331 [TBL] [Abstract][Full Text] [Related]
6. Carcinogen biomarkers for lung or oral cancer chemoprevention trials. Hecht SS IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664 [TBL] [Abstract][Full Text] [Related]
8. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933 [TBL] [Abstract][Full Text] [Related]
9. Early detection and chemoprevention of lung cancer. Shaipanich T; McWilliams A; Lam S Respirology; 2006 Jul; 11(4):366-72. PubMed ID: 16771906 [TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of lung cancer: from concept to reality. van Zandwijk N Rocz Akad Med Bialymst; 2003; 48():5-10. PubMed ID: 14737934 [TBL] [Abstract][Full Text] [Related]
12. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579 [TBL] [Abstract][Full Text] [Related]
13. [Biomarkers of carcinogenesis of the upper and lower airway epithelium and the role of chemoprevention]. Soria JC; Izzo J; Mao L; Hong WK; Papadimitrakopoulou VA Bull Cancer; 2001 Apr; 88(4):351-61. PubMed ID: 11371369 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Schuller HM; Porter B; Riechert A; Walker K; Schmoyer R Lung Cancer; 2004 Jul; 45(1):11-8. PubMed ID: 15196729 [TBL] [Abstract][Full Text] [Related]
15. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk]. Sanner T; Dybing E Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210 [TBL] [Abstract][Full Text] [Related]
16. Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials. De Flora S; Camoirano A; Bagnasco M; Bennicelli C; van Zandwijk N; Wigbout G; Qian GS; Zhu YR; Kensler TW J Cell Biochem Suppl; 1996; 25():92-8. PubMed ID: 9027604 [TBL] [Abstract][Full Text] [Related]
17. [Chemoprevention of bronchogenic carcinoma]. Votruba J; St'astný B Cas Lek Cesk; 2000 Nov; 139(22):702-4. PubMed ID: 11191751 [TBL] [Abstract][Full Text] [Related]